XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL…
June 02, 2025 19:30 ET | Source: Semilux International Ltd. Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International…